期刊
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
卷 16, 期 2, 页码 83-90出版社
JAPAN ATHEROSCLEROSIS SOC
DOI: 10.5551/jat.E091
关键词
Type 2 diabetes mellitus; Eicosapentaenoic acid; Adiponectin; Endothelial cell-derived microparticle; Angiopoietin 2
资金
- Japan Foundation of Neuropsychiatry and Hematology Research
- Ministry of Health and Welfare of Japan
- Ministry of Education, Science and Culture of Japan [13670760]
Aim: The aim of this study was to evaluate the significance of endothelial cell-derived microparticles (EDMP), angiopoictin-2 (Ang-2) and adiponectin in hyperlipidemic patients with and without type 2 diabetes mellitus, and to compare the two for the effects of eicosapentaenoic acid (EPA) on these markers. Methods: One hundred and twenty-six hyperlipidemic patients with and without type 2 diabetes mellitus received EPA 1,800 mg daily, and 50 of the patients were non-diabetic. Results: EDMP and Ang-2 levels prior to treatment were higher in diabetic patients than in non-diabetic patients, whereas adiponectin levels were lower in diabetics. When diabetic patients were classified into two groups on the basis of Ang-2 levels, the levels of all markers remained unchanged in those without a high Ang-2 level after EPA treatment. In contrast, all markers except for adiponectin were decreased significantly in diabetic patients with high Ang-2 levels after 6 months of EPA treatment. These diabetic patients with high Ang-2 levels displayed a more significant increase in adiponectin levels after EPA treatment than those who did not. Conclusion: These results suggest that EPA possesses an adiponectin-dependent anti-atherosclerotic effect and may be beneficial for the prevention of vascular complications in diabetic patients with high Ang-2 levels.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据